Literature DB >> 12780694

Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections.

C C Hermsen1, Y Konijnenberg, L Mulder, C Loé, M van Deuren, J W M van der Meer, G J van Mierlo, W M C Eling, C E Hack, R W Sauerwein.   

Abstract

Release of soluble Granzymes (sGranzymes) is considered to reflect activation of cytotoxic T lymphocytes and NK cells. sGranzymes and a number of pro-inflammatory cytokines were measured in plasma of malaria patients with natural or experimentally induced Plasmodium falciparum infections. Concentrations of sGranzyme A and B, IL-10, IL-12p70 and CRP were significantly increased in African children presenting with clinical malaria; IL-10 and CRP concentrations were significantly correlated with disease severity. In nonimmune Dutch volunteers which were experimentally infected by P. falciparum-infected mosquitoes, sGranzyme A increment started 1-2 days prior to clinical symptoms and microscopically detectable parasitaemia. This coincided with increases in IFNgamma, IL-12p40 and IL-8, while sGranzyme B and IL-10 levels increased 24-48 h later. The elevation of sGranzyme A and IFNgamma in nonimmune volunteers suggests that NK cells are activated upon release of parasites by infected liver cells and subsequently during blood stage infection; thus, NK cells are likely involved innate immune human host resistance in the early phase of a malaria infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780694      PMCID: PMC1808730          DOI: 10.1046/j.1365-2249.2003.02160.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.

Authors:  R Harpaz; R Edelman; S S Wasserman; M M Levine; J R Davis; M B Sztein
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.

Authors:  B Lowin; M Hahne; C Mattmann; J Tschopp
Journal:  Nature       Date:  1994-08-25       Impact factor: 49.962

3.  Measurement by membrane feeding of reduction in Plasmodium falciparum transmission induced by endemic sera.

Authors:  A Lensen; J van Druten; M Bolmer; G van Gemert; W Eling; R Sauerwein
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Jan-Feb       Impact factor: 2.184

4.  Increased systemic levels of soluble granzymes A and B during primary cytomegalovirus infection after renal transplantation.

Authors:  I J ten Berge; P C Wever; A M Wolbink; J Surachno; P M Wertheim; L H Spaeny; C E Hack
Journal:  Transplant Proc       Date:  1998-12       Impact factor: 1.066

5.  Liver CD4-CD8- NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro.

Authors:  S Pied; J Roland; A Louise; D Voegtle; V Soulard; D Mazier; P A Cazenave
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

6.  Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity.

Authors:  J Renggli; M Hahne; H Matile; B Betschart; J Tschopp; G Corradin
Journal:  Parasite Immunol       Date:  1997-03       Impact factor: 2.280

Review 7.  The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes.

Authors:  R C Bleackley; C G Lobe; B Duggan; N Ehrman; C Fregeau; M Meier; M Letellier; C Havele; J Shaw; V Paetkau
Journal:  Immunol Rev       Date:  1988-03       Impact factor: 12.988

8.  alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.

Authors:  G Gonzalez-Aseguinolaza; C de Oliveira; M Tomaska; S Hong; O Bruna-Romero; T Nakayama; M Taniguchi; A Bendelac; L Van Kaer; Y Koezuka; M Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

9.  Complement activation in patients with sepsis is in part mediated by C-reactive protein.

Authors:  G J Wolbink; A W Bossink; A B Groeneveld; M C de Groot; L G Thijs; C E Hack
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

10.  Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.

Authors:  M E Molyneux; T E Taylor; J J Wirima; A Borgstein
Journal:  Q J Med       Date:  1989-05
View more
  37 in total

Review 1.  Effect of malaria components on blood mononuclear cells involved in immune response.

Authors:  Chuchard Punsawad
Journal:  Asian Pac J Trop Biomed       Date:  2013-09

2.  Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin.

Authors:  Jonas Klingström; Jonas Hardestam; Malin Stoltz; Bartek Zuber; Ake Lundkvist; Stig Linder; Clas Ahlm
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum.

Authors:  Myriam Baratin; Sophie Roetynck; Catherine Lépolard; Christine Falk; Serge Sawadogo; Satoshi Uematsu; Shizuo Akira; Bernhard Ryffel; Jean-Gérard Tiraby; Lena Alexopoulou; Carsten J Kirschning; Jürg Gysin; Eric Vivier; Sophie Ugolini
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

4.  Antimalarial activity of granzyme B and its targeted delivery by a granzyme B-single-chain Fv fusion protein.

Authors:  Stephanie Kapelski; Melanie de Almeida; Rainer Fischer; Stefan Barth; Rolf Fendel
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

5.  Haplotypes of IL12B promoter polymorphisms condition susceptibility to severe malaria and functional changes in cytokine levels in Thai adults.

Authors:  Chintana Phawong; Collins Ouma; Piyatida Tangteerawatana; Jarinee Thongshoob; Tom Were; Yuvadee Mahakunkijcharoen; Duangrurdee Wattanasirichaigoon; Douglas Jay Perkins; Srisin Khusmith
Journal:  Immunogenetics       Date:  2010-04-13       Impact factor: 2.846

6.  Elastase and granzymes during meningococcal disease in children: correlation to disease severity.

Authors:  Job B M van Woensel; Maarten H Biezeveld; C Erik Hack; Albert P Bos; Taco W Kuijpers
Journal:  Intensive Care Med       Date:  2005-07-12       Impact factor: 17.440

7.  γδ T Cells Kill Plasmodium falciparum in a Granzyme- and Granulysin-Dependent Mechanism during the Late Blood Stage.

Authors:  Maria Andrea Hernández-Castañeda; Katharina Happ; Filippo Cattalani; Alexandra Wallimann; Marianne Blanchard; Isabelle Fellay; Brigitte Scolari; Nils Lannes; Smart Mbagwu; Benoît Fellay; Luis Filgueira; Pierre-Yves Mantel; Michael Walch
Journal:  J Immunol       Date:  2020-02-17       Impact factor: 5.422

8.  Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

Authors:  Else M Bijker; Guido J H Bastiaens; Anne C Teirlinck; Geert-Jan van Gemert; Wouter Graumans; Marga van de Vegte-Bolmer; Rianne Siebelink-Stoter; Theo Arens; Karina Teelen; Wiebke Nahrendorf; Edmond J Remarque; Will Roeffen; Annemieke Jansens; Dunja Zimmerman; Martijn Vos; Ben C L van Schaijk; Jorien Wiersma; André J A M van der Ven; Quirijn de Mast; Lisette van Lieshout; Jaco J Verweij; Cornelus C Hermsen; Anja Scholzen; Robert W Sauerwein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-18       Impact factor: 11.205

9.  CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions.

Authors:  Toshimichi Matsui; John E Connolly; Mark Michnevitz; Damien Chaussabel; Chun-I Yu; Casey Glaser; Sasha Tindle; Marc Pypaert; Heidi Freitas; Bernard Piqueras; Jacques Banchereau; A Karolina Palucka
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

10.  Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas.

Authors:  Catherine S Forconi; Cormac P Cosgrove; Pryia Saikumar-Lakshmi; Christina E Nixon; Joslyn Foley; John Michael Ong'echa; Juliana A Otieno; Galit Alter; Christian Münz; Ann M Moormann
Journal:  Blood Adv       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.